TICKERNOMICS Sign up
Last Update: 2024-12-27 15:30:12
Aclarion Inc. ( ACON ) https://www.aclarion.com
0.14USD
Sector:
Healthcare
Industry:
Health Information Services
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-95.97%
ACON
SPY
32.66%
ACON
0.00%
SPY
108.59%
ACON
0.00%
SPY
302.52%
ACON
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1.21
0.76
1.40
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.19
24.51
0.48
-356.58
0.00
-0.16
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-8995.34
-48.07
-9643.20
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-152.96
-667.94
0.00
Other Earnings and Cash Flow Stats:
Aclarion Inc. ( ACON ) Net Income TTM ($MM) is -6.27
Aclarion Inc. ( ACON ) Operating Income TTM ($MM) is -4.83
Aclarion Inc. ( ACON ) Owners' Earnings Annual ($MM) is 0.00
Aclarion Inc. ( ACON ) Current Price to Owners' Earnings ratio is 0.00
Aclarion Inc. ( ACON ) EBITDA TTM ($MM) is -4.65
Aclarion Inc. ( ACON ) EBITDA Margin is -9643.20%
Capital Allocation:
Aclarion Inc. ( ACON ) has paid 0.00 dividends per share and bought back -8.904943 million shares in the past 12 months
Aclarion Inc. ( ACON ) has reduced its debt by 1.4375 million USD in the last 12 months
Capital Structure:
Aclarion Inc. ( ACON ) Interest-bearing Debt ($MM) as of last quarter is 0
Aclarion Inc. ( ACON ) Annual Working Capital Investments ($MM) are 0
Aclarion Inc. ( ACON ) Book Value ($MM) as of last quarter is 2
Aclarion Inc. ( ACON ) Debt/Capital as of last quarter is 52%
Other Balance Sheet Stats:
Aclarion Inc. ( ACON ) has 1 million in cash on hand as of last quarter
Aclarion Inc. ( ACON ) has 0 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Aclarion Inc. ( ACON ) has 9 common shares outstanding as of last quarter
Aclarion Inc. ( ACON ) has 0 million USD of preferred stock value
Academic Scores:
Aclarion Inc. ( ACON ) Altman Z-Score is -25.27 as of last quarter
Aclarion Inc. ( ACON ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Aclarion Inc. ( ACON ) largest shareholder is Whittier Trust Co owning 4820 shares at 0.00 ($MM) value
Jeffrey John Thramann(an insider) Bought 0 shares of Aclarion Inc. ( ACON ) for the amount of $0.00 on 2023-02-16
10.05% of Aclarion Inc. ( ACON ) is held by insiders, and 3.12% is held by institutions
Aclarion Inc. ( ACON ) went public on 2022-04-22
Other Aclarion Inc. ( ACON ) financial metrics:
FCF:-5.19
Unlevered Free Cash Flow:0.00
EPS:-0.58
Operating Margin:-8995.34
Gross Profit Margin:-48.07
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-217.74
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Aclarion Inc. ( ACON ) :
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.